NPPA

(redirected from natriuretic peptide A)

NPPA

A gene on chromosome 1p36.21 that encodes a member of the natriuretic peptide family, which control extracellular fluid volume and electrolyte homeostasis.
 
Molecular pathology
NPPA mutations are associated with atrial fibrillation familial type 6.
References in periodicals archive ?
Bakker, "Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects," Journal of the American College of Cardiology, vol.
[7] Human genes: NPPA, natriuretic peptide A; NPPB, natriuretic peptide B.
[3] Human genes: NPPB, natriuretic peptide B; NPPC, natriuretic peptide C; NPPA, natriuretic peptide A; FURIN, furin (paired basic amino acid cleaving enzyme).
Brain natriuretic peptide as a cardiac marker of transient radiotherapy-related damage in left-sided breast cancer patients: A prospective study.
Hashimoto et al., "N-terminal probrain natriuretic peptide as a predictor of heart failure with preserved ejection fraction in hemodialysis patients without fluid overload," Blood Purification, vol.
Vollmar, "Induction of I[kappa]B: atrial natriuretic peptide as a regulator of the NF-[kappa]B pathway," Biochemical and Biophysical Research Communications, vol.
Kinoshita, "Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction," The American Heart Journal, vol.
Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
Comparison of atrial natriuretic peptide, B-type natriuretic peptide and N terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
B-type natriuretic peptide as an indicator of right ventricular dysfunction in acute pulmonary embolism.